Advertisement

Cancer Causes & Control

, Volume 26, Issue 6, pp 955–956 | Cite as

Preeclampsia and subsequent breast cancer risk

  • Lionel Carbillon
  • Claire Delahosseraye
Letter to the editor

Keywords

Vascular Endothelial Growth Factor Breast Cancer Risk Preeclampsia Vascular Endothelial Growth Factor Receptor Eclampsia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Prebil LA, Ereman RR, Powell MJ (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25:859–868CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683CrossRefPubMedGoogle Scholar
  3. 3.
    Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8:1088–1100CrossRefPubMedGoogle Scholar
  4. 4.
    Cheng D, Hao Y, Zhou W et al (2013) Vascular endothelial growth factor +936C/T, −634G/C, −2578C/A, and −1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS ONE 8:e78173CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Troisi R, Braekke K, Harsem NK et al (2008) Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol 199:653.e1–653.e10CrossRefGoogle Scholar
  6. 6.
    Zhou Y, Genbacev O, Fisher SJ (2003) The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 995:73–83CrossRefPubMedGoogle Scholar
  7. 7.
    Parr C, Watkins G, Boulton M et al (2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41:2819–2827CrossRefPubMedGoogle Scholar
  8. 8.
    Bear HD, Tang G, Rastogi P et al (2012) Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med 366:310–320CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Assistance Publique Hopitaux de ParisParis 13 UniversityBondyFrance

Personalised recommendations